AMAG Pharma (AMAG) Tops Q2 EPS by 25c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. BROS
3. ARM
4. FIS
5. EXPE
6. QCOM
7. DDOG
8. PAYC
9. CHYM
10. CPAY

Go back to AMAG Pharma (AMAG) Tops Q2 EPS by 25c

AMAG Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update

August 9, 2016 7:31 AM EDT

Total GAAP quarterly product and service revenues increased approximately 50% to $127 million

Makena® (hydroxyprogesterone caproate injection) and Feraheme® (ferumoxytol) achieve record sales

Significant progress on next generation Makena and Feraheme development programs

Conference call scheduled for 8:00 a.m. ET today

WALTHAM, Mass., Aug. 09, 2016 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today reported unaudited consolidated financial results for the second quarter ended June 30, 2016. Total product and service revenues for the second quarter of 2016... More